机译:前进:2015年国际儿童肿瘤基金会会议1型,2型,2型和施曼仔病症
Johns Hopkins University School of MedicineBaltimore Maryland;
Children's Tumor FoundationNew York New York;
Arizona State UniversityTempe Arizona;
Indiana UniversityIndianapolis Indiana;
Guy's Hospital and St. Thomas’ HospitalLondon United Kingdom;
Children's Hospital of PhiladelphiaPhiladelphia Pennsylvania;
University of California Los AngelesLos Angeles California;
Washington University School of MedicineSt. Louis Missouri;
New York University Medical CenterNew York New York;
Scripps Research InstituteJupiter Florida;
Center for Human Genetics‐University HospitalLeuven Belgium;
MRC Laboratory for Molecular Cell BiologyUniversity CollegeLondon United Kingdom;
Children's National Medical CenterWashington District of Columbia;
Harvard Medical SchoolBoston Massachusetts;
The Neurofibromatosis InstituteLa Crescenta California;
Lucille Packard Children's Hospital StanfordPalo Alto California;
Boston Children's HospitalHarvard Medical SchoolBoston Massachusetts;
Institute of Cancer GeneticsCardiff UniversityWales United Kingdom;
Massachusetts General HospitalHarvard Medical SchoolBoston Massachusetts;
neurofibromatosis type 1; neurofibromatosis type 2; pediatric tumors; rare disease; schwannomatosis; therapeutic discovery;
机译:前进:2015年国际儿童肿瘤基金会会议1型,2型,2型和施曼仔病症
机译:与1型神经纤维瘤,2型神经鞘瘤和神经鞘瘤相关的肿瘤的治疗进展
机译:在神经纤维瘤病1型,神经纤维瘤病2型和施曼仔病症中成像的现状及建议
机译:使用虚拟教室环境描述1型神经纤维瘤病儿童的注意力缺陷状况
机译:I型神经纤维瘤病鼠模型的见解:周围神经鞘瘤的病因和适当的治疗窗口
机译:稀有13。神经纤维瘤病患者1(NF1)和丛状神经纤维瘤儿童的特征和治疗模式(PN):儿童肿瘤基础(CTF)注册表数据的横截面分析
机译:前进的道路:2015年国际儿童肿瘤基金会关于1型,2型和神经鞘瘤病的神经纤维瘤会议